tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AIM ImmunoTech reports data in year-end update from Phase 2 trial of Ampligen
PremiumThe FlyAIM ImmunoTech reports data in year-end update from Phase 2 trial of Ampligen
6d ago
AIM ImmunoTech Inc trading resumes
Premium
The Fly
AIM ImmunoTech Inc trading resumes
18d ago
AIM ImmunoTech Inc trading halted, news pending
Premium
The Fly
AIM ImmunoTech Inc trading halted, news pending
18d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AIM ImmunoTech Completes 2025 Annual Stockholder Meeting
Premium
Company Announcements
AIM ImmunoTech Completes 2025 Annual Stockholder Meeting
2M ago
AIM ImmunoTech Delays Q3 2025 Report Filing
PremiumCompany AnnouncementsAIM ImmunoTech Delays Q3 2025 Report Filing
3M ago
AIM Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AIM Upcoming Earnings Report: What to Expect?
3M ago
AIM ImmunoTech details UPMC abstract on completed Ampligen trial
Premium
The Fly
AIM ImmunoTech details UPMC abstract on completed Ampligen trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100